Colgate-Palmolive (India) reports Q3 profit decline due to soft urban demand, focuses on driving growth through innovation.

CL's Q4 results are expected to reflect gains from pricing, funding-the-growth and other productivity initiatives, supporting ...

On the other hand, Colgate-Palmolive has seen better revenue growth over the recent quarters and is trading at a relatively lower valuation. Now, looking at prospects, using P/S as a base ...

There is more to the comparison, and in the sections below, we discuss why we think CL will outperform KMB in the next three ...

BofA Securities adjusted its price target for Colgate-Palmolive (NYSE:CL) India (CLGT:IN) to INR2,930 from the previous INR2,955 while maintaining a Buy rating on the stock. The revision follows the ...

Morgan Stanley analyst Dara Mohsenian maintained a Buy rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...

In 2011, Colgate-Palmolive removed a chemical called triclosan from its soap products, citing "changing consumer preferences." But according to a New York Times article, the change was more likely ...

Ahead of the event, analysts expect Colgate to report a non-GAAP profit of $0.90 per share, up 3.5% from $0.87 per share reported in the year-ago quarter. The company has a robust earnings ...

Colgate Palmolive (India) reported a third-quarter profit that came in below market estimates on Tuesday, hurt by dwindling demand from urban consumers and higher expenses.

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders ...